ANVS as of Oct 31 · 08:15 ET
ANVSNYSEPharmaceutical Preparations

Annovis Bio, Inc. · Brief

Next report

11 days

Nov 11 · after closeest.Q3 FY26

Expected move

No implied move.

Implied vs realized

1 reportHistory
—≥ implied
Q2 FY26±37.6%▼−5.95%×0.16
quarterimplied−40%0+40%realized×
Q2 FY26±37.6%▼−5.95%×0.16
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 11 report · est.

Bull2

3 of 19small proportion of the largest reporting managers cut their stake this quarter13F · Jun 30 '26
+59.06%change in shares held by largest reporting managers over the latest quarter13F · Jun 30 '26

Bear1

8managers hold the bulk of reported position value13F · Jun 30 '26
AI captions · Oct 26 '26once per report · top 2 per case

Linked exposure

ANVS report session

No linked exposure.

Latest changes

30 daysAll changes

No changes.

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.